Aarkstore - Resistant Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014 - PowerPoint PPT Presentation

About This Presentation
Title:

Aarkstore - Resistant Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014

Description:

This report provides comprehensive information on the therapeutic development for Resistant Pseudomonas Aeruginosa Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Browse full report @ – PowerPoint PPT presentation

Number of Views:52

less

Transcript and Presenter's Notes

Title: Aarkstore - Resistant Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014


1
Resistant Pseudomonas Aeruginosa Infections -
Pipeline Review, H2 2014
Healthcare Market Research Reports
2
Summary
  • Resistant Pseudomonas Aeruginosa Infections -
    Pipeline Review, H2 2014, provides an overview
    of the Resistant Pseudomonas Aeruginosa
    Infectionss therapeutic pipeline.This report
    provides comprehensive information on the
    therapeutic development for Resistant Pseudomonas
    Aeruginosa Infections, complete with comparative
    analysis at various stages, therapeutics
    assessment by drug target, mechanism of action
    (MoA), route of administration (RoA) and molecule
    type, along with latest updates, and featured
    news and press releases. It also reviews key
    players involved in the therapeutic development
    for Resistant Pseudomonas Aeruginosa Infections
    and special features on late-stage and
    discontinued projects.
  • Global Markets Directs report features
    investigational drugs from across globe covering
    over 20 therapy areas and nearly 3,000
    indications. The report is built using data and
    information sourced from Global Markets Directs
    proprietary databases, Company/University
    websites, SEC filings, investor presentations and
    featured press releases from company/university
    sites and industry-specific third party sources,
    put together by Global Markets Directs team.
    Drug profiles/records featured in the report
    undergoes periodic updation following a stringent
    set of processes that ensures that all the
    profiles are updated with the latest set of
    information. 

3
Scope
  • - The report provides a snapshot of the global
    therapeutic landscape of Resistant Pseudomonas
    Aeruginosa Infections- The report reviews key
    pipeline products under drug profile section
    which includes, product description, MoA and RD
    brief, licensing and collaboration details
    other developmental activities - The report
    reviews key players involved in the therapeutics
    development for Resistant Pseudomonas Aeruginosa
    Infections and enlists all their major and minor
    projects- The report summarizes all the dormant
    and discontinued pipeline projects - A review of
    the Resistant Pseudomonas Aeruginosa Infections
    products under development by companies and
    universities/research institutes based on
    information derived from company and
    industry-specific sources- Pipeline products
    coverage based on various stages of development
    ranging from pre-registration till discovery and
    undisclosed stages- A detailed assessment of
    monotherapy and combination therapy pipeline
    projects- Coverage of the Resistant Pseudomonas
    Aeruginosa Infections pipeline on the basis of
    target, MoA, route of administration and molecule
    type- Latest news and deals relating related to
    pipeline products

4
Reasons to buy
  • - Provides strategically significant competitor
    information, analysis, and insights to formulate
    effective RD development strategies- Identify
    emerging players with potentially strong product
    portfolio and create effective counter-strategies
    to gain competitive advantage- Develop strategic
    initiatives by understanding the focus areas of
    leading companies- Identify and understand
    important and diverse types of therapeutics under
    development for Resistant Pseudomonas Aeruginosa
    Infections- Plan mergers and acquisitions
    effectively by identifying key players of the
    most promising pipeline- Devise corrective
    measures for pipeline projects by understanding
    Resistant Pseudomonas Aeruginosa Infections
    pipeline depth and focus of Indication
    therapeutics- Develop and design in-licensing
    and out-licensing strategies by identifying
    prospective partners with the most attractive
    projects to enhance and expand business potential
    and Scope- Modify the therapeutic portfolio by
    identifying discontinued projects and
    understanding the factors that drove them from
    pipeline

5
Table of Content
  • List of Tables 5List of Figures 5Introduction
    6Global Markets Direct Report Coverage
    6Resistant Pseudomonas Aeruginosa Infections
    Overview 7Therapeutics Development 8Pipeline
    Products for Resistant Pseudomonas Aeruginosa
    Infections - Overview 8Pipeline Products for
    Resistant Pseudomonas Aeruginosa Infections -
    Comparative Analysis 9Resistant Pseudomonas
    Aeruginosa Infections - Therapeutics under
    Development by Companies 10Resistant Pseudomonas
    Aeruginosa Infections - Therapeutics under
    Investigation by Universities/Institutes
    11Resistant Pseudomonas Aeruginosa Infections -
    Pipeline Products Glance 12Clinical Stage
    Products 12Early Stage Products 13Resistant
    Pseudomonas Aeruginosa Infections - Products
    under Development by Companies 14

6
List of Tables
  • Number of Products under Development for
    Resistant Pseudomonas Aeruginosa Infections, H2
    2014 8Number of Products under Development for
    Resistant Pseudomonas Aeruginosa Infections -
    Comparative Analysis, H2 2014 9Number of
    Products under Development by Companies, H2 2014
    10Number of Products under Investigation by
    Universities/Institutes, H2 2014 11Comparative
    Analysis by Clinical Stage Development, H2 2014
    12Comparative Analysis by Early Stage
    Development, H2 2014 13Products under
    Development by Companies, H2 2014 14Products
    under Investigation by Universities/Institutes,
    H2 2014 15Resistant Pseudomonas Aeruginosa
    Infections - Pipeline by AstraZeneca PLC, H2 2014
    16Resistant Pseudomonas Aeruginosa Infections -
    Pipeline by Biolytics Pharma, H2 2014
    17Resistant Pseudomonas Aeruginosa Infections -
    Pipeline by FOB Synthesis, Inc., H2 2014
    18Resistant Pseudomonas Aeruginosa Infections -
    Pipeline by LegoChem Biosciences, Inc, H2 2014 19

7
List of Figures
  • Number of Products under Development for
    Resistant Pseudomonas Aeruginosa Infections, H2
    2014 8Number of Products under Development for
    Resistant Pseudomonas Aeruginosa Infections -
    Comparative Analysis, H2 2014 9Number of
    Products under Development by Companies, H2 2014
    10Comparative Analysis by Clinical Stage
    Development, H2 2014 12Comparative Analysis by
    Early Stage Products, H2 2014 13Assessment by
    Monotherapy Products, H2 2014 25Number of
    Products by Top 10 Targets, H2 2014 27Number of
    Products by Stage and Top 10 Targets, H2 2014
    27Number of Products by Top 10 Mechanism of
    Actions, H2 2014 29Number of Products by Stage
    and Top 10 Mechanism of Actions, H2 2014
    29Number of Products by Top 10 Routes of
    Administration, H2 2014 31Number of Products by
    Stage and Top 10 Routes of Administration, H2
    2014 31Number of Products by Top 10 Molecule
    Types, H2 2014 33

8
Browse Full Report
  • Or Sample Request _at_
  • http//www.aarkstore.com/healthcare/89708/resistan
    t-pseudomonas-aeruginosa-infections-pipeline-revie
    w-h2

9
Related Reports
  • Healthcare IT (HIT) Market in the APAC Region
    2015-2019
  • Complete 2015-16 Induced Pluripotent Stem Cell
    (iPSC) Industry Report
  • Colposcopy Test, Market, Users Forecast - Asia
    Middle East Analysis
  • Asia Intrauterine Device (IUD) Market, Users
    Forecast
  • Global Nuclear Imaging Market 2015-2019
  • Point of Care Diagnostic Testing World Markets
  • European Non-Invasive Minimally Invasive
    Cardiac Output Monitoring Devices Market
  • Europe Laboratory Information System Market

10
Follow Us
https//www.facebook.com/aarkstoredotcom
https//twitter.com/aarkstore
https//plus.google.com/Aarkstoredotcom/posts
https//www.linkedin.com/company/aarkstore-enterpr
ise
11
Contact Us
Office Address Office No. - 809, 8th
Floor,B-Wing, Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Mail us at
contact_at_aarkstore.com 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
Write a Comment
User Comments (0)
About PowerShow.com